Terms: = Liver cancer AND CgA AND Diagnosis
39 results:
1. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
4. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
[TBL] [Abstract] [Full Text] [Related]
5. Feature Selection and Classification of Clinical Datasets Using Bioinspired Algorithms and Super Learner.
Murugesan S; Bhuvaneswaran RS; Khanna Nehemiah H; Keerthana Sankari S; Nancy Jane Y
Comput Math Methods Med; 2021; 2021():6662420. PubMed ID: 34055041
[TBL] [Abstract] [Full Text] [Related]
6. Thymic Carcinoid as the First Manifestation of Multiple Endocrine Neoplasia Type 1 Syndrome: A Case Report and Review of the Literature.
Zheng M; Chen S; Qi C; Ren L; Zhen Y; Yu X; Wei L
Ann Clin Lab Sci; 2020 Nov; 50(6):825-833. PubMed ID: 33334800
[TBL] [Abstract] [Full Text] [Related]
7. Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population.
Hong L; Wang Y; Zhang T; Zhang C; Wang L; Wang L; Wang Z; Zhong J
Med Sci Monit; 2020 Nov; 26():e926635. PubMed ID: 33141811
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant β-catenin Activity in Hepatoid Adenocarcinoma of the Stomach.
Wang N; Kong R; Han W; Lu J
Curr Mol Med; 2021; 21(8):655-664. PubMed ID: 32442081
[TBL] [Abstract] [Full Text] [Related]
9. Primary hepatic neuroendocrine tumors: A case report.
Hu HX; Yu T
Medicine (Baltimore); 2019 Dec; 98(50):e18278. PubMed ID: 31852101
[TBL] [Abstract] [Full Text] [Related]
10. Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature.
Gaiani F; de'Angelis N; Minelli R; Kayali S; Carra MC; de'Angelis GL
Medicine (Baltimore); 2019 Sep; 98(37):e17154. PubMed ID: 31517859
[TBL] [Abstract] [Full Text] [Related]
11. Blood mRNA Measurement (NETest) for Neuroendocrine Tumor diagnosis of Image-Negative liver Metastatic Disease.
Malczewska A; Bodei L; Kidd M; Modlin IM
J Clin Endocrinol Metab; 2019 Mar; 104(3):867-872. PubMed ID: 30358858
[TBL] [Abstract] [Full Text] [Related]
12. Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report.
Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic neuroendocrine pancreatic tumor - Case report.
Radu EC; Saizu AI; Grigorescu RR; Croitoru AE; Gheorghe C
J Med Life; 2018; 11(1):57-61. PubMed ID: 29696066
[No Abstract] [Full Text] [Related]
14. Pre-operative diagnosis of Pancreatic Neuroendocrine Tumors with Endoscopic Ultrasonography and Computed Tomography in a Large Series.
Manta R; Nardi E; Pagano N; Ricci C; Sica M; Castellani D; Bertani H; Piccoli M; Mullineris B; Tringali A; Marini F; Germani U; Villanacci V; Casadei R; Mutignani M; Conigliaro R; Bassotti G; Zullo A
J Gastrointestin Liver Dis; 2016 Sep; 25(3):317-21. PubMed ID: 27689195
[TBL] [Abstract] [Full Text] [Related]
15. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan.
Ito T; Hijioka S; Masui T; Kasajima A; Nakamoto Y; Kobayashi N; Komoto I; Hijioka M; Lee L; Igarashi H; Jensen RT; Imamura M
J Gastroenterol; 2017 Jan; 52(1):9-18. PubMed ID: 27539256
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Tian T; Gao J; Li N; Li Y; Lu M; Li Z; Lu Z; Li J; Shen L
PLoS One; 2016; 11(5):e0154679. PubMed ID: 27159453
[TBL] [Abstract] [Full Text] [Related]
17. [Management of treatment in patients with neuroendocrine neoplasmas of digestive tract].
Kinová S; Kovácová M; Caprnda M; Koren M
Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S12-20. PubMed ID: 27124967
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors.
Kim M; Lee S; Lee J; Park SH; Park JO; Park YS; Kang WK; Kim ST
Cancer Res Treat; 2016 Jan; 48(1):153-61. PubMed ID: 25779359
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
Denecke T; Baur AD; Ihm C; Steffen IG; Tischer E; Arsenic R; Pascher A; Wiedenmann B; Pavel M
Eur J Radiol; 2013 Oct; 82(10):e550-5. PubMed ID: 23891296
[TBL] [Abstract] [Full Text] [Related]
[Next]